Two elderly patients with normal creatinine and elevated cystatin C – a case report by unknown
CASE REPORT Open Access
Two elderly patients with normal creatinine
and elevated cystatin C – a case report
Amina Loesment-Wendelmuth1, Elke Schaeffner2 and Natalie Ebert2*
Abstract
Background: Serum creatinine concentration (Scr) and creatinine based GFR estimating equations (eGFRcr) are
commonly used as an estimate of GFR. However, serum creatinine concentration is also influenced by non-GFR
determinants. This case report presents two elderly patients with normal Scr but elevated serum cystatin C
concentration (Scys) where the exclusive assessment of Scr would have lead to an overestimation of GFR and
would have misclassified the patients as having a normal kidney function.
Case presentation: Patient 1, a 102-year-old woman, presented with a Scr of 0.45 mg/dl, while her Scys was
elevated (1.55 mg/l). Depending on which of the five GFR estimating equations was used, the patient could be
classified into four different CKD-Stages (2, 3a, 3b and 4). The largest difference between the eGFR-results was
94 ml/min/1.73 m2 (Δ-eGFR).
Patient 2, an 88-year-old man, also had normal Scr (0.93 mg/dl) but elevated Scys (1.55 mg/l). An iohexol clearance
measurement yielded a measured GFR (mGFR) of 44 ml/min/1.73 m2. Four out of five GFR equations would have
overestimated the patient’s kidney function.
Conclusion: The presented cases highlight the influence of non-GFR determinants on Scr and demonstrate the
variability of eGFR results depending on the filtration marker and GFR equation used. Especially for older adults,
it shows the great clinical importance of understanding the limitations of each filtration marker and of identifying
situations in which relying on eGFRcr alone can lead to false estimation of kidney function. In these situations,
cysC based GFR equations may provide improved accuracy of GFR assessment and may protect patients from drug
overdosing and the abundant use of contrast agents.
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Background
Generally, the serum concentration of an endogenous
filtration marker, such as creatinine, is used as a rough
estimate of the glomerular filtration rate (GFR) and is
also the central element of all GFR estimating equations.
In an equilibrium of endogenous production and renal elim-
ination, creatinine correlates inversely with GFR. Its serum
concentration however, can be influenced by non-GFR
determinants such as muscle mass. Cystatin C is another
endogenous filtration marker but only very rarely routinely
monitored. This case report presents two elderly patients
with perfectly normal serum creatinine concentration (Scr),
but clearly elevated serum cystatin C concentration (Scys).
The exclusive assessment of creatinine would have most
probably misclassified these patients as being “kidney-
healthy”. Thus, it highlights the importance of putting serum
creatinine levels into the individual patient context and of
identifying situations in which further assessment of kidney
function, using ScysC or even direct measurement of GFR
(mGFR), is needed.
Case presentation
A 102-year-old woman (patient 1) took part in the Berlin
Initiative Study (BIS), a large prospective population-
based cohort study focusing on the epidemiology of
chronic kidney disease in older adults. Her only pre-
existing condition was a peripheral artery disease. Per-
manent medication included pantoprazole and novamin-
sulfon on a regular basis and magnesium as needed. The
physical examination yielded a height of 156 cm and
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weight of 42 kg corresponding to a body mass index
(BMI) of 17 kg/m2. Her resting blood pressure and pulse
were 151/69 mmHg and 78/min, respectively. The pa-
tient’s lab results revealed haemoglobin 10.6 g/dl, CRP
1.28 mg/l, urea 28 mg/dl, albumin 30.2 g/l, calcium
2.27 mmol/l, phosphate 1.12 mmol/l. Albumin-creatinine-
ratio (ACR) was below 30 mg/g.
At presentation, Scr was within the normal range
(0.45 mg/dl), while Scys was elevated (1.55 mg/l). GFR es-
timating equations (eGFR) yielded the following results:
MDRD [1]: 128 ml/min/1.73 m2, CKD-Epicr [2]: 82 ml/
min/1.73 m2, FAS [3]: 79 ml/min/1.73 m2, BIS1 [4]:
76 ml/min/1.73 m2, CKD-Epicr/cys [5]: 53 ml/min/1.73 m
2,
BIS2 [4]: 50 ml/min/1.73 m2, and CKD-Epicys [5]: 34 ml/
min/1.73 m2. The largest difference between creatinine-
based eGFR-results (Δ-eGFRcr) was 49, between all
equations 94 ml/min/1.73 m2. Thus, based on eGFR re-
sults the patient could at the same time be classified into
four different CKD-stages (2, 3a, 3b and 4), depending on
the GFR estimating equation used (see Fig. 1).
Patient 2 was an 88-year old male participant of the
BIS study. Beside a diagnosis of arterial hypertension, he
had no history of further chronic illnesses. A beta-
blocker was his only permanent daily medication. His
height was 167 cm and he weighed 69 kg (BMI 25 kg/
m2). His resting blood pressure was 213/89 mmHg, his
heart rate 89 bpm. Blood analysis yielded the following
results: haemoglobin 13.1 g/dl, CRP 0.61 mg/l, urea
43 mg/dl, albumin 35.5 g/l, calcium 1.98 mmol/l, phos-
phate 0.98 mmol/l. ACR was below 30 mg/g.
Similar to the first patient, his Scr was within the nor-
mal range (0.93 mg/dl), while his Scys was elevated to
1.77 mg/l. This corresponded to the following eGFR-
results: MDRD: 77 ml/min/1.73 m2, CKD-Epicr: 73 ml/
min/1.73 m2, FAS: 58 ml/min/1.73 m2, BIS1: 56 ml/min/
1.73 m2, CKD-Epicr/cys: 48 ml/min/1.73 m
2, BIS2: 43 ml/
min/1.73 m2, CKD-Epicys: 33 ml/min/1.73 m
2. The
largest difference between eGFR-results was 40 ml/min/
1.73 m2 (Δ-eGFR). This patient belonged to the BIS sub-
group in which measurement of GFR using iohexol
plasma clearance had been conducted. His measured
GFR (mGFR) was 44 ml/min/1.73 m2, which demon-
strated that four out of five eGFR-equations would have
overestimated his kidney function (see Fig. 1).
When analyzing the population of the Berlin Initiative
Study (n = 2096, mean age 80.4 years) 607 participants
showed the combination of a normal Scr concentration
(men: <1.17 mg/dl; women: <0.95 mg/dl) and an
elevated Scys level (men and women: >0,96 mg/l). This
resulted in 29% of the BIS participants being classified as
having a normal kidney function in case only Scr had
been taken into consideration.
Fig. 1 Estimated GFR results depending on different equations in patient 1 and 2
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Discussion
Scr has been abundantly used for the assessment of GFR
for almost 100 years. However, glomerular filtration is
only one of several variables that determine creatinine
concentration. In certain clinical situations, relying on
creatinine based GFR estimating equations (eGFRcr) alone
can lead to false estimation of kidney function. The
presented cases demonstrate impressively the strong
influence of non-GFR determinants on creatinine concen-
tration. In addition, they highlight the variability of eGFR
results depending on (1) the filtration marker and (2)
eGFR equation used. It is thus of great clinical importance
to understand the value and shortcomings of each
filtration marker to be able to identify situations in which
certain markers, in this case eGFRcr, are less accurate [6].
For the described patients, low creatinine generation
due to low muscular mass was certainly the most
influential non-GFR determinant. Low muscular mass is
common in the elderly due to muscle wasting and
malnutrition, being accompanied by a decreased serum
creatinine, which in turn leads to an overestimation of
kidney function. In our cohort study, which exclusively
consists of individuals over 70 years, one third of these
participants showed the combination of a normal Scr with
an elevated Scys. Against the background of demographic
aging clinicians should be aware of the effect of a dimin-
ishing muscular mass on serum creatinine concentration.
Other non-GFR determinants that cause a decline in
serum creatinine are a protein- and meat-reduced diet,
increased excretion by tubular secretion or gastrointes-
tinal elimination [7] as well as increased extracellular fluid
[8]. On the other hand, certain medication (trimethoprim,
cimetidin, fenofibrat) inhibit tubular secretion of creatin-
ine or decrease extrarenal elimination by inhibition of the
gut creatinase (certain antibiotics), resulting in higher
serum creatinine levels and thus leading to an underesti-
mation of kidney function [9].
In certain situations (i.e. age ≥70 years, malnutrition,
liver cirrhosis, edema, diabetic hyperfiltration), Scys based
GFR estimating equations (eGFRcys) may therefore pro-
vide an improved accuracy of GFR assessment and CKD-
classification. Scys is produced at a constant rate in all
nucleated cells [10] and in contrast to creatinine its rate of
production is independent of muscular mass and gender.
Determining Scys in the two cases described above will
thus protect patients from drug overdosing and from the
abundant use of contrast agents.
There are however non-GFR determinants that influence
Scys such as inflammation, obesity (probably due to proin-
flammatory properties of adipocytes) autoimmune disease,
hyperthyreosis, malignoma and nicotine consumption [11].
Some of them are very common in older age as well (i.e. in-
flammation). Even more, there are studies that suggest that
Scys might increase with age, which would in turn lead to
an underestimation of GFR in older adults [12, 13]. Unfortu-
nately we had no mGFR in patient 1 which would have pro-
vided a definite GFR value given the fact that patient 1 also
had slightly increased CRP suggesting mild inflammation.
In conclusion, especially in older adults clinicians should
appreciate the limitations of endogenous filtration markers.
Their awareness needs to be sharpened to take individual
patient characteristics (in our cases especially cachexia,
muscle wasting, malnutrition) into consideration in order
to identify constellations where creatinine is insufficient. In
such situations cystatin C-based eGFR equations should be
preferred. In other situations, i.e. states of inflammation
Scys might not be the ideal marker. Thus, in older vulner-
able adults where sometimes crucial decisions have to me
made such as dosage of nephrotoxic drugs or the eligibility
of kidney donation, direct clearance measurement should
be considered as a reasonable alternative since the accurate
determination of renal function can be vitally important.
Conclusion
The presented case report demonstrates impressively the
strong influence of non-GFR determinants on creatinine
concentration and highlights that the choice of renal
markers for assessing kidney function should be consid-
ered very cautiously, especially in older adults. Also, it in-
dicates circumstances where cystatin C may be a superior
biomarker for clinical decision-making and refers to situa-
tions where measured GFR should be considered.
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